FDA Approves First Treatment for Children With Menkes Disease

Quarterly IID Change Log displays changes made since the previous quarterly IID publication.

FDA does not issue approval announcements for every approval or drug label update that occurs in oncology and hematology. Please refer to Drugs@FDA for the latest approvals and prescribing information for specific products.

Information and resources for requestors about FDA’s Biomarker Qualification Program

FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing and to provide the data necessary for the FDA to make a GRASE determination for sunscreen active ingredients.

Clinical Investigator (Sponsor)

If a user rapidly presses two or more on-screen buttons, the NOxBOXi Nitric Oxide Delivery System may experience sudden software interruption or restart.